DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Jacobson IM, Lawitz E, Gane EJ. , et al.
Efficacy of 8 weeks of sofosbuvir, velpatasvir, and voxilaprevir in patients with chronic HCV infection: 2 Phase 3 randomized trials.
Gastroenterology 2017;
153 (01) 113-122
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.